Search

everythinglearnresearchcommunity

for

Search:↓

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

Hair loss may increase heart disease risk.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

No definitive link between finasteride and male breast cancer, but further research is needed.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Insulin resistance and nesfatin-1 are linked to acne severity.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.